Post by UCB

At #EAN2026, UCB will be presenting analyses exploring long-term outcomes in generalized myasthenia gravis (gMG) in adult patients and supporting a symposium aiming to educate attendees on key patient factors involved in treatment decisions. By continuing to build evidence across a range of lived experiences, we hope to support a broader understanding of long-term disease management and the evolving needs of people living with #gMG.